Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020)

Oncology Institute (DFPH) posted Long-Term Deferred Tax of $70000.0 for Q3 2020, up 79.49% quarter-over-quarter from $39000.0 in Q2 2020.

Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends

Oncology Institute (DFPH) has reported Long-Term Deferred Tax for 2 consecutive years, with $70000.0 the latest figure, recorded in Q3 2020.

Long-Term Deferred Tax for Q3 2020 came in at $70000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $70000.0 (changed N/A YoY), and the FY2019 annual result was $300.0, changed N/A from the prior year.
Long-Term Deferred Tax was $70000.0 for Q3 2020 at Oncology Institute, up from $39000.0 in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $70000.0 in Q3 2020 and troughed at $300.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	87.94 Bn	90.32 Bn	16.26 Bn
2	Chemed	18.08 Bn	18.07 Bn	215.76 Mn
3	Tenet Healthcare	16.59 Bn	15.76 Bn	4.41 Bn
4	Davita	15.37 Bn	16.23 Bn	1.07 Bn
5	Encompass Health	10.07 Bn	10.70 Bn	1.34 Bn
6	Ensign	9.52 Bn	8.93 Bn	293.37 Mn
7	Universal Health Services	9.19 Bn	9.15 Bn	3.21 Bn
8	Pacs	6.96 Bn	6.72 Bn	345.96 Mn
9	Ww International	6.14 Bn	5.98 Bn	-149.29 Mn
10	Oncology Institute	-	-	139.16 Mn

Download Data